Campaign India Team
Jul 06, 2011

Draftfcb+Ulka Healthcare appoints Dr. Sushil Motwani as business head

Motwani brings with him a medical background, combined with 12 years experience in product management

Draftfcb+Ulka Healthcare appoints Dr. Sushil Motwani as business head

The healthcare arm of Draftfcb+ Ulka, India’s fourth largest advertising agency has brought on board Dr. Sushil Motwani as Business Head. Motwani brings with him a medical background, combined with 12 years experience in product management. In his earlier assignment, he has steered many extensive communication programs with clients like Bayer Diabetes Care, Biogen Idec, Pfizer, Aristo, Novartis, Galderma & Lupin, working closely with the marketing teams to build campaigns addressing the doctor, sales force and the patients.

A press note from the agency also informed that the division recently bagged the Astra Zeneca’s Branded Generics business. AstraZeneca is now aiming at inorganic growth by launching generic brands in the international markets. Motwani would be spearheading the agency’s communication effort in this direction which would involve doctor communication developed in India for the international markets.
 

Source:
Campaign India

Related Articles

Just Published

14 hours ago

Paramount launches hostile $104 billion cash bid to ...

Totalling $25 billion higher than Netflix’s bid, analysts say whichever company ultimately secures WBD will gain a decisive advantage in the streaming wars.

16 hours ago

Advertisers are watching Australia’s teen social ...

Under-16 digital behaviour in Australia is about to change, and ripple effects for brands will be everywhere.

17 hours ago

Mirror, EMIs and the postponed dream of retirement

Kotak Life’s latest ad reframes retirement as reinvention, using a mirror monologue to tackle India’s chronic tendency to postpone long-term planning.

18 hours ago

India’s E&M industry projected to grow 7.8%: PWC

The industry is expected to grow from $32.2 billion in 2024 to $47.2 billion by 2029, nearly twice the global average of 4.2%.